| US11685775B2 | 27 June 2023 | Grant | US16901596 | Method of increasing the ratio of effector t cells to regulatory t cells in a tumor by administering to a subject a tgf-beta inhibitor and a pd-1 antibody | Regents of the University of California; XOMA Technology Ltd |
|---|
| US11534428B1 | 27 December 2022 | Grant | US16411974 | Compositions and methods for delaying the incidence of labor | XOMA (US) LLC |
|---|
| US11261247B2 | 1 March 2022 | Grant | US15921176 | Modulators | XOMA (US) LLC |
|---|
| US11098111B2 | 24 August 2021 | Grant | US16435022 | Method of treating cancer by administering an antibody that binds transforming growth factor beta (TGF-beta) 1, tgf-beta 2 and tgf-beta 3 | XOMA Technology Ltd |
|---|
| US11034759B2 | 15 June 2021 | Grant | US16158642 | Humanized m-csf specific monoclonal antibodies, kits, and uses thereof | Novartis Vaccines and Diagnostics Inc; XOMA Technology Ltd |
|---|
